Stratos Wealth Partners LTD. acquired a new stake in shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA) during the second quarter, Holdings Channel reports. The institutional investor acquired 13,310 shares of the healthcare company’s stock, valued at approximately $280,000.

Shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA) opened at 21.31 on Thursday. The firm has a 50-day moving average price of $21.29 and a 200 day moving average price of $20.67. Davis Select U.S. Equity ETF has a 12 month low of $19.79 and a 12 month high of $21.78.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at

About Davis Select U.S. Equity ETF

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

Want to see what other hedge funds are holding DUSA? Visit to get the latest 13F filings and insider trades for Davis Select U.S. Equity ETF (NASDAQ:DUSA).

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with's FREE daily email newsletter.